The Predictive Disease Analytics Market is projected to grow from USD 2.6 Billion in 2023 to USD 13.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 23.20%. This growth is driven by the need to improve operations and provide better patient care in the healthcare sector. The market is segmented by component (Software & Services and Hardware), deployment (On-premise and Cloud-based), end user (Healthcare Payers, Healthcare Providers, and Other End Users), and region (North America, Europe, Asia-Pacific, and Rest Of The World).
